Luas Diagnostics develops user-friendly diagnostic tests for infectious diseases, including a home-to-laboratory test for Group B Streptococcus in pregnancy. Their products enable individuals and healthcare professionals to conduct accurate testing at home or at the Point-Of-Care, improving access to essential health information.
Funding
$510K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pregnant women face the risk of Group B Streptococcus (GBS) infection, which can lead to serious complications for both mother and newborn. Traditional GBS testing often requires clinic visits and laboratory processing, creating delays and access barriers. The need for rapid and convenient GBS screening is critical for timely intervention and improved maternal and infant health outcomes.
Solution
Luas Diagnostics offers a suite of diagnostic tests, including Strepelle, a home-to-laboratory test for Group B Streptococcus (GBS) in pregnant women. Strepelle allows individuals to collect samples at home and send them to a certified laboratory for analysis, streamlining the testing process and reducing the need for in-person clinic visits. Luas Diagnostics also distributes a range of infectious disease tests for both home and point-of-care use, including an HIV self-test that delivers results in 10 minutes. By providing accessible and user-friendly diagnostic solutions, Luas Diagnostics empowers individuals and healthcare professionals to proactively manage their health.
Target Audience
The primary target audience includes pregnant women seeking convenient and reliable GBS screening, individuals requiring discreet HIV self-testing, and healthcare professionals needing point-of-care diagnostic solutions.
Features
- Strepelle: A home-to-laboratory test for Group B Streptococcus (GBS) screening during pregnancy.
- HIV Self-Test: A CE-marked single-use test that detects HIV-1&2 antibodies from a fingerstick blood sample in 10 minutes.
- Distribution of infectious disease tests for home and point-of-care use.
- Tests available for a range of infectious diseases and cancer.